DRUG实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases...

Stats
今日成交量	6 013.00
平均成交量	24 788.00
市值	4.75M
EPS	$0 ( 2024-02-06 )
下一个收益日期	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.850
ATR14	$0.0140 (1.27%)

Bright Minds Biosciences 相关性

10 最正相关
IRBT	0.964
NDAQ	0.958
HCAQ	0.952
LGMK	0.934
INCR	0.93
REYN	0.929
ADTN	0.929
LSXMA	0.926
LSXMK	0.926
CFRX	0.924

10 最负相关
INSE	-0.959
MCFT	-0.956
PATK	-0.954
BCOR	-0.949
VAQC	-0.946
TZPSU	-0.941
LYTS	-0.94
ULTA	-0.937
TMKR	-0.936
AMTBB	-0.936

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Bright Minds Biosciences 财务报表

Annual	2023
营收:	$0
毛利润:	$-72 450.00 (0.00 %)
EPS:	$-1.980

FY	2023
营收:	$0
毛利润:	$-72 450.00 (0.00 %)
EPS:	$-1.980

FY	2023
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$0

FY	2022
营收:	$0
毛利润:	$-6 037.00 (0.00 %)
EPS:	$-6.15

Financial Reports:

No articles found.

Bright Minds Biosciences

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.